AMGN logo

Amgen (AMGN) Free Cash Flow

Annual FCF

$7.36 B
-$1.43 B-16.23%

31 December 2023

AMGN Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

$3.31 B
+$1.09 B+49.21%

30 September 2024

AMGN Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

$6.28 B
+$802.00 M+14.63%

30 September 2024

AMGN TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AMGN Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.2%+31.9%-33.0%
3 y3 years-25.6%+52.3%-19.9%
5 y5 years-30.3%+3.3%-31.5%

AMGN Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-25.6%at low-13.7%+1046.7%-35.1%+14.6%
5 y5 years-30.3%at low-13.7%+1046.7%-38.6%+14.6%
alltimeall time-30.3%>+9999.0%-13.7%+4639.7%-42.2%>+9999.0%

Amgen Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
$3.31 B(+49.2%)
$6.28 B(+14.6%)
June 2024
-
$2.22 B(+383.9%)
$5.48 B(-22.8%)
Mar 2024
-
$459.00 M(+58.8%)
$7.10 B(-3.5%)
Dec 2023
$7.36 B(-16.2%)
$289.00 M(-88.5%)
$7.36 B(-21.5%)
Sept 2023
-
$2.51 B(-34.5%)
$9.38 B(-3.2%)
June 2023
-
$3.84 B(+433.1%)
$9.69 B(+28.6%)
Mar 2023
-
$720.00 M(-68.8%)
$7.53 B(-14.3%)
Dec 2022
$8.79 B(+4.8%)
$2.31 B(-18.1%)
$8.79 B(-2.4%)
Sept 2022
-
$2.82 B(+67.3%)
$9.00 B(+7.7%)
June 2022
-
$1.68 B(-14.7%)
$8.36 B(-0.7%)
Mar 2022
-
$1.97 B(-21.7%)
$8.42 B(+0.4%)
Dec 2021
$8.38 B(-15.2%)
$2.52 B(+15.9%)
$8.38 B(+6.9%)
Sept 2021
-
$2.18 B(+24.6%)
$7.84 B(-11.9%)
June 2021
-
$1.75 B(-9.9%)
$8.90 B(-9.5%)
Mar 2021
-
$1.94 B(-2.1%)
$9.84 B(-0.5%)
Dec 2020
$9.89 B(+15.9%)
$1.98 B(-38.8%)
$9.89 B(-3.4%)
Sept 2020
-
$3.23 B(+20.5%)
$10.23 B(+0.3%)
June 2020
-
$2.68 B(+34.7%)
$10.21 B(+16.1%)
Mar 2020
-
$1.99 B(-14.4%)
$8.79 B(+3.1%)
Dec 2019
$8.53 B(-19.2%)
$2.33 B(-27.5%)
$8.53 B(-7.0%)
Sept 2019
-
$3.21 B(+152.5%)
$9.18 B(+1.2%)
June 2019
-
$1.27 B(-26.5%)
$9.07 B(-6.6%)
Mar 2019
-
$1.73 B(-41.8%)
$9.71 B(-8.0%)
Dec 2018
$10.56 B(+0.4%)
$2.97 B(-4.3%)
$10.56 B(+1.1%)
Sept 2018
-
$3.10 B(+62.0%)
$10.45 B(-1.8%)
June 2018
-
$1.92 B(-25.5%)
$10.64 B(-2.1%)
Mar 2018
-
$2.57 B(-10.0%)
$10.87 B(+3.4%)
Dec 2017
$10.51 B(+9.3%)
$2.86 B(-13.3%)
$10.51 B(-0.1%)
Sept 2017
-
$3.30 B(+53.9%)
$10.53 B(+7.1%)
June 2017
-
$2.14 B(-3.4%)
$9.82 B(-2.5%)
Mar 2017
-
$2.22 B(-22.8%)
$10.07 B(+4.8%)
Dec 2016
$9.62 B(+5.2%)
$2.87 B(+10.8%)
$9.62 B(+11.7%)
Sept 2016
-
$2.59 B(+8.5%)
$8.61 B(-2.4%)
June 2016
-
$2.39 B(+35.9%)
$8.82 B(-7.5%)
Mar 2016
-
$1.76 B(-5.8%)
$9.53 B(+4.3%)
Dec 2015
$9.14 B(+14.9%)
$1.87 B(-33.4%)
$9.14 B(-6.5%)
Sept 2015
-
$2.80 B(-9.6%)
$9.77 B(+4.1%)
June 2015
-
$3.10 B(+127.3%)
$9.39 B(+12.5%)
Mar 2015
-
$1.36 B(-45.5%)
$8.34 B(+5.0%)
Dec 2014
$7.95 B(+42.0%)
$2.50 B(+3.4%)
$7.95 B(+12.3%)
Sept 2014
-
$2.42 B(+17.9%)
$7.08 B(+12.5%)
June 2014
-
$2.05 B(+111.8%)
$6.29 B(+10.8%)
Mar 2014
-
$970.00 M(-40.6%)
$5.68 B(+1.4%)
Dec 2013
$5.60 B(+8.3%)
$1.63 B(+0.1%)
$5.60 B(+23.0%)
Sept 2013
-
$1.63 B(+13.3%)
$4.55 B(+1.8%)
June 2013
-
$1.44 B(+61.7%)
$4.47 B(-14.6%)
Mar 2013
-
$891.00 M(+51.8%)
$5.23 B(+1.2%)
Dec 2012
$5.17 B(+13.5%)
$587.00 M(-62.1%)
$5.17 B(-13.0%)
Sept 2012
-
$1.55 B(-29.6%)
$5.94 B(+13.4%)
June 2012
-
$2.20 B(+166.1%)
$5.24 B(+17.8%)
Mar 2012
-
$828.00 M(-39.1%)
$4.45 B(-2.2%)
Dec 2011
$4.55 B(-12.6%)
$1.36 B(+60.2%)
$4.55 B(-9.3%)
Sept 2011
-
$849.00 M(-39.9%)
$5.02 B(-6.1%)
June 2011
-
$1.41 B(+51.9%)
$5.34 B(+0.5%)
Mar 2011
-
$930.00 M(-49.1%)
$5.32 B(+2.1%)
Dec 2010
$5.21 B(-10.3%)
$1.83 B(+55.4%)
$5.21 B(+2.9%)
Sept 2010
-
$1.18 B(-15.3%)
$5.06 B(-11.7%)
June 2010
-
$1.39 B(+69.4%)
$5.73 B(-2.6%)
Mar 2010
-
$819.00 M(-51.2%)
$5.88 B(+1.3%)
Dec 2009
$5.81 B(+9.2%)
$1.68 B(-9.0%)
$5.81 B(+8.6%)
Sept 2009
-
$1.84 B(+19.8%)
$5.35 B(+13.0%)
June 2009
-
$1.54 B(+107.5%)
$4.73 B(+1.9%)
Mar 2009
-
$742.00 M(-39.1%)
$4.65 B(-12.6%)
Dec 2008
$5.32 B(+28.6%)
$1.22 B(-1.0%)
$5.32 B(-1.4%)
Sept 2008
-
$1.23 B(-15.3%)
$5.39 B(-0.9%)
June 2008
-
$1.45 B(+3.0%)
$5.44 B(+9.4%)
Mar 2008
-
$1.41 B(+9.0%)
$4.98 B(+20.4%)
Dec 2007
$4.13 B(-0.9%)
$1.30 B(+1.1%)
$4.13 B(+11.9%)
Sept 2007
-
$1.28 B(+29.8%)
$3.70 B(+2.4%)
June 2007
-
$988.00 M(+73.9%)
$3.61 B(-4.5%)
Mar 2007
-
$568.00 M(-33.8%)
$3.78 B(-9.4%)
DateAnnualQuarterlyTTM
Dec 2006
$4.17 B(+3.1%)
$858.00 M(-28.3%)
$4.17 B(-0.1%)
Sept 2006
-
$1.20 B(+3.4%)
$4.18 B(-1.1%)
June 2006
-
$1.16 B(+20.9%)
$4.22 B(+3.6%)
Mar 2006
-
$958.00 M(+10.9%)
$4.08 B(+0.8%)
Dec 2005
$4.04 B(+71.3%)
$864.00 M(-30.5%)
$4.04 B(+1.3%)
Sept 2005
-
$1.24 B(+22.8%)
$3.99 B(+13.3%)
June 2005
-
$1.01 B(+9.4%)
$3.53 B(+7.7%)
Mar 2005
-
$925.00 M(+13.6%)
$3.27 B(+38.6%)
Dec 2004
$2.36 B(+6.8%)
$814.00 M(+5.0%)
$2.36 B(+1.8%)
Sept 2004
-
$775.00 M(+2.1%)
$2.32 B(+28.5%)
June 2004
-
$759.00 M(+5738.5%)
$1.81 B(+5.6%)
Mar 2004
-
$13.00 M(-98.3%)
$1.71 B(-22.6%)
Dec 2003
$2.21 B(+39.0%)
$773.00 M(+196.7%)
$2.21 B(+10.5%)
Sept 2003
-
$260.50 M(-60.8%)
$2.00 B(+9.0%)
June 2003
-
$663.90 M(+29.5%)
$1.83 B(+8.1%)
Mar 2003
-
$512.60 M(-9.0%)
$1.70 B(+6.8%)
Dec 2002
$1.59 B(+53.1%)
$563.20 M(+494.1%)
$1.59 B(+11.9%)
Sept 2002
-
$94.80 M(-82.0%)
$1.42 B(-5.5%)
June 2002
-
$527.10 M(+30.2%)
$1.50 B(+23.8%)
Mar 2002
-
$404.90 M(+2.7%)
$1.21 B(+17.0%)
Dec 2001
$1.04 B(-13.2%)
$394.20 M(+121.8%)
$1.04 B(+15.9%)
Sept 2001
-
$177.70 M(-25.3%)
$896.20 M(-25.1%)
June 2001
-
$238.00 M(+4.2%)
$1.20 B(-2.3%)
Mar 2001
-
$228.50 M(-9.3%)
$1.22 B(+2.2%)
Dec 2000
$1.20 B(+55.2%)
$252.00 M(-47.2%)
$1.20 B(+14.7%)
Sept 2000
-
$477.30 M(+79.6%)
$1.04 B(+27.1%)
June 2000
-
$265.80 M(+31.7%)
$820.60 M(-3.3%)
Mar 2000
-
$201.80 M(+105.1%)
$848.50 M(+10.0%)
Dec 1999
$771.10 M(+21.7%)
$98.40 M(-61.4%)
$771.10 M(-10.8%)
Sept 1999
-
$254.60 M(-13.3%)
$864.90 M(+11.9%)
June 1999
-
$293.70 M(+136.1%)
$772.80 M(+30.4%)
Mar 1999
-
$124.40 M(-35.3%)
$592.70 M(-6.5%)
Dec 1998
$633.70 M(+23.0%)
$192.20 M(+18.3%)
$633.70 M(+8.7%)
Sept 1998
-
$162.50 M(+43.0%)
$583.00 M(+12.3%)
June 1998
-
$113.60 M(-31.3%)
$519.20 M(-5.8%)
Mar 1998
-
$165.40 M(+16.9%)
$550.90 M(+7.0%)
Dec 1997
$515.10 M(-7.3%)
$141.50 M(+43.4%)
$515.10 M(-6.5%)
Sept 1997
-
$98.70 M(-32.1%)
$551.10 M(+4.4%)
June 1997
-
$145.30 M(+12.1%)
$528.00 M(-16.8%)
Mar 1997
-
$129.60 M(-27.0%)
$634.50 M(+14.2%)
Dec 1996
$555.70 M(-9.0%)
$177.50 M(+134.8%)
$555.70 M(+1.5%)
Sept 1996
-
$75.60 M(-70.0%)
$547.30 M(-10.2%)
June 1996
-
$251.80 M(+395.7%)
$609.50 M(+15.0%)
Mar 1996
-
$50.80 M(-70.0%)
$530.00 M(-13.2%)
Dec 1995
$610.50 M(+52.2%)
$169.10 M(+22.7%)
$610.50 M(+3.8%)
Sept 1995
-
$137.80 M(-20.0%)
$588.40 M(+6.4%)
June 1995
-
$172.30 M(+31.2%)
$552.90 M(+22.1%)
Mar 1995
-
$131.30 M(-10.7%)
$452.70 M(+12.9%)
Dec 1994
$401.10 M(+79.8%)
$147.00 M(+43.7%)
$401.10 M(+0.8%)
Sept 1994
-
$102.30 M(+41.9%)
$397.80 M(-0.9%)
June 1994
-
$72.10 M(-9.5%)
$401.30 M(+6.8%)
Mar 1994
-
$79.70 M(-44.5%)
$375.80 M(+68.4%)
Dec 1993
$223.10 M(+205.6%)
$143.70 M(+35.8%)
$223.10 M(+121.8%)
Sept 1993
-
$105.80 M(+127.0%)
$100.60 M(+1664.9%)
June 1993
-
$46.60 M(-163.8%)
$5.70 M(-141.6%)
Mar 1993
-
-$73.00 M(-444.3%)
-$13.70 M(-118.8%)
Dec 1992
$73.00 M(-28.7%)
$21.20 M(+94.5%)
$73.00 M(+40.9%)
Sept 1992
-
$10.90 M(-59.9%)
$51.80 M(+26.7%)
June 1992
-
$27.20 M(+98.5%)
$40.90 M(+198.5%)
Mar 1992
-
$13.70 M(-141.1%)
$13.70 M(-126.7%)
Dec 1991
$102.40 M(-299.2%)
-
-
Mar 1991
-
-$33.30 M(-27.0%)
-$51.40 M(+715.9%)
Mar 1991
-$51.40 M(+102.4%)
-
-
Dec 1990
-
-$45.60 M(+744.4%)
-$6.30 M(-117.3%)
Sept 1990
-
-$5.40 M(-116.4%)
$36.40 M(+118.0%)
June 1990
-
$32.90 M(+178.8%)
$16.70 M(-165.7%)
Mar 1990
-$25.40 M(-48.3%)
$11.80 M(-506.9%)
-$25.40 M(-31.7%)
Dec 1989
-
-$2.90 M(-88.4%)
-$37.20 M(+8.5%)
Sept 1989
-
-$25.10 M(+172.8%)
-$34.30 M(+272.8%)
June 1989
-
-$9.20 M
-$9.20 M
Mar 1989
-$49.10 M
-
-

FAQ

  • What is Amgen annual free cash flow?
  • What is the all time high annual FCF for Amgen?
  • What is Amgen annual FCF year-on-year change?
  • What is Amgen quarterly free cash flow?
  • What is the all time high quarterly FCF for Amgen?
  • What is Amgen quarterly FCF year-on-year change?
  • What is Amgen TTM free cash flow?
  • What is the all time high TTM FCF for Amgen?
  • What is Amgen TTM FCF year-on-year change?

What is Amgen annual free cash flow?

The current annual FCF of AMGN is $7.36 B

What is the all time high annual FCF for Amgen?

Amgen all-time high annual free cash flow is $10.56 B

What is Amgen annual FCF year-on-year change?

Over the past year, AMGN annual free cash flow has changed by -$1.43 B (-16.23%)

What is Amgen quarterly free cash flow?

The current quarterly FCF of AMGN is $3.31 B

What is the all time high quarterly FCF for Amgen?

Amgen all-time high quarterly free cash flow is $3.84 B

What is Amgen quarterly FCF year-on-year change?

Over the past year, AMGN quarterly free cash flow has changed by +$802.00 M (+31.93%)

What is Amgen TTM free cash flow?

The current TTM FCF of AMGN is $6.28 B

What is the all time high TTM FCF for Amgen?

Amgen all-time high TTM free cash flow is $10.87 B

What is Amgen TTM FCF year-on-year change?

Over the past year, AMGN TTM free cash flow has changed by -$3.10 B (-33.01%)